Histone methyl-transferase G9a inhibition boosts the efficacy of immune checkpoint inhibitors in experimental hepatocellular carcinoma.

Adan-Villaescusa E, Castello-Uribe B, Uriarte I, Santamaria E, Barbero R, Belzunce M, López-Pascual A, Latasa MU, Elurbide J, Valbuena-Goiricelaya E, Mesropian A, Cano-Segarra G, Hernández de Sande A, Nevi L, Carotti S, Vespasiani-Gentilucci U, Prosper F, Pineda-Lucena A, Sangro B, Argemi J, Berraondo P, Sarobe P, Gris-Oliver A, Pinyol R, Llovet JM, Arechederra M, Berasain C, Cocozaki A, Gibaja V, Avila MA, Fernandez-Barrena MG

Open source

DOI: 10.1016/j.xcrm.2026.102717
Published: 2026 Apr 21
Container: Cell reports. Medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.xcrm.2026.102717,
  title = {Histone methyl-transferase G9a inhibition boosts the efficacy of immune checkpoint inhibitors in experimental hepatocellular carcinoma.},
  author = {Adan-Villaescusa E and Castello-Uribe B and Uriarte I and Santamaria E and Barbero R and Belzunce M and López-Pascual A and Latasa MU and Elurbide J and Valbuena-Goiricelaya E and Mesropian A and Cano-Segarra G and Hernández de Sande A and Nevi L and Carotti S and Vespasiani-Gentilucci U and Prosper F and Pineda-Lucena A and Sangro B and Argemi J and Berraondo P and Sarobe P and Gris-Oliver A and Pinyol R and Llovet JM and Arechederra M and Berasain C and Cocozaki A and Gibaja V and Avila MA and Fernandez-Barrena MG},
  year = {2026},
  journal = {Cell reports. Medicine},
  doi = {10.1016/j.xcrm.2026.102717},
  url = {https://doi.org/10.1016/j.xcrm.2026.102717}
}

RIS

TY  - JOUR
TI  - Histone methyl-transferase G9a inhibition boosts the efficacy of immune checkpoint inhibitors in experimental hepatocellular carcinoma.
AU  - Adan-Villaescusa E
AU  - Castello-Uribe B
AU  - Uriarte I
AU  - Santamaria E
AU  - Barbero R
AU  - Belzunce M
AU  - López-Pascual A
AU  - Latasa MU
AU  - Elurbide J
AU  - Valbuena-Goiricelaya E
AU  - Mesropian A
AU  - Cano-Segarra G
AU  - Hernández de Sande A
AU  - Nevi L
AU  - Carotti S
AU  - Vespasiani-Gentilucci U
AU  - Prosper F
AU  - Pineda-Lucena A
AU  - Sangro B
AU  - Argemi J
AU  - Berraondo P
AU  - Sarobe P
AU  - Gris-Oliver A
AU  - Pinyol R
AU  - Llovet JM
AU  - Arechederra M
AU  - Berasain C
AU  - Cocozaki A
AU  - Gibaja V
AU  - Avila MA
AU  - Fernandez-Barrena MG
PY  - 2026
JO  - Cell reports. Medicine
DO  - 10.1016/j.xcrm.2026.102717
UR  - https://doi.org/10.1016/j.xcrm.2026.102717
ER  -

APA

E, A., B, C., I, U., E, S., R, B., M, B., A, L., MU, L., J, E., E, V., A, M., G, C., A, H. D. S., L, N., S, C., U, V., F, P., A, P., B, S., J, A., P, B., P, S., A, G., R, P., JM, L., M, A., C, B., A, C., V, G., MA, A., & MG, F. (2026). Histone methyl-transferase G9a inhibition boosts the efficacy of immune checkpoint inhibitors in experimental hepatocellular carcinoma.. Cell reports. Medicine. https://doi.org/10.1016/j.xcrm.2026.102717

Source records

pubmed · retrieved 2026-09-27T08:38:08.310Z